FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4539911000001108: Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21325901000001118 Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38430601000001118 Furosemide 40mg / Potassium chloride 600mg (potassium 8mmol) modified-release tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Is pack of Furosemide 40mg / Potassium 8mmol modified-release tablets false Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has active ingredient Furosemide false Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has VMP Furosemide 40mg / Potassium 8mmol modified-release tablets true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has specific active ingredient Furosemide true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Diumide-K Continus tablets (Teofarma S.r.l.) 30 tablet 5 x 6 tablets Is a True Furosemide 40mg / Potassium 8mmol modified-release tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start